* Rahsaan Thompson, Chief Legal & Compliance Officer at Zevra Therapeutics, sold 42,666 common shares on Aug. 14, 2026. * Weighted average sale price was **$11.13** per share. * The directly held stake fell to **37,569** common shares following the sale.